baber/WOPTO huggingface dataset:
Patent EP-3761870-A1 (EP)
Inventor: MATUSAITIS TOMAS
IPC: A61B17/56
Filed: 2019-03-05
Abstract: The invention is a system and a handheld device for use in open or minimally invasive surgical procedures, such as a bone implant fixation procedure. The handheld device is configured to perform various functions during a bone implant fixation procedure, including performing at least one of: penetration of a bone to form a hole or opening for receipt of a screw; neuromonitoring, in cooperation with a neuromonitoring device, of the hole during, or post-, formation of the hole so as to sense any nearby nerves adjacent to the hole that may be in the path of a screw, or otherwise affected, when a screw is placed within the hole; neurostimulation, in cooperation with a neuromonitoring device, of nerves adjacent to the hole during, or post-, formation of the hole; and measuring of a depth of the hole and providing a digital measurement of the depth to assist the surgeon in selecting the appropriate length of screw.
Patent EP-3847156-A1 (EP)
Inventor: MALPART JOËL
IPC: C07D207/12
Filed: 2019-09-06
Abstract: Herein are provided novel salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate namely the oxalate salt (I) and the dibenzoyltartrate salt (II).
Patent EP-3740857-A1 (EP)
Inventor: LEE JINYEONG
IPC: G06F3/0488
Filed: 2019-03-22
Abstract: An electronic device is provided. The electronic device includes housing, a touchscreen display, a wireless communication circuit, a connector, and a processor electrically connected to the touchscreen display, the wireless communication circuit, and the connector. The processor is configured to connect to an external display device via the wireless communication circuit or the connector, to display a graphical user interface corresponding to a screen, which the external display device outputs, in at least part of a region of the touchscreen display, to display at least part of a region of the graphical user interface in a black background, and to convert first coordinate information of a user input, which is received with respect to at least one region of the graphical user interface, to second coordinate information corresponding to the external display device to transmit the second coordinate information to the external display device.
Patent EP-3850528-A1 (EP)
Inventor: FERNANDEZ-ORELLANA PEDRO
IPC: G06F30/00
Filed: 2019-09-13
Abstract: A method of designing a fire suppression system including: generating one or more fire suppression system designs in response to building information, building requirements, and pre-defined optimization preferences; receiving a user input selection for fire suppression system parameters in real-time; refining the one or more fire suppression system designs in response to input selections for fire suppression system parameters; and receiving a user input selection for a final chosen design of the one or more fire suppression system designs.
Patent EP-4028993-A1 (EP)
Inventor: TAN DAVID JOSEPH
IPC: G06T7/73
Filed: 2019-09-13
Abstract: Example embodiments allow for fast, efficient detection and pose estimation of objects based on point clouds, depth images/maps, or other depth information about a scene that may contain the objects. Embodiments include translating and rotating the depth image to bring individual points of the depth image to a standard orientation and location so as to improve performance when an object is near the periphery of the field of view. Some disclosed embodiments include applying a random forest to perform pose estimation. By using the decision trees or other fast methods, it can be advantageous to perform pose estimation a plurality of times prior to identifying whether a particular object is actually present in a scene. Prospective pose estimates can be combined with models of the objects in order to evaluate whether the object is present in the scene.
Patent EP-3852858-A1 (EP)
Inventor: ISAACSON S RAY
IPC: A61M25/00
Filed: 2019-09-18
Abstract: An apparatus may include a connector (10), which may include a proximal end (14) and a distal end (16). The distal end of the connector may include a male luer adapter, which may be configured to couple with a proximal end of a catheter adapter. The apparatus may include a catheter (12), which may include a proximal end secured within the connector. The catheter may be configured to extend through an indwelling peripheral intravenous catheter. The catheter may include a closed distal end (24) and a slit (26) adjacent to the closed distal end. The slit may be closed under normal physiological pressures.
Patent EP-3814974-A1 (EP)
Inventor: FANGHAENEL THOMAS
IPC: G06F40/12
Filed: 2019-09-23
Abstract: Systems, devices, and techniques are disclosed for translation of tenant identifiers. A record may be received. A value of a tenant identifier for the record may be determined from a key for the record or a scan descriptor. The value of the tenant identifier in the key for the record may be replaced with a new value for the tenant identifier. A bitmap stored in a record header of the record may be used to identify columns of the record that stored an encoded value of the tenant identifier. An encoded new value of the tenant identifier may be stored in columns identified by the bitmap stored in the record header that include an attribute indicating that tenant identifier translation is enabled.
Patent EP-3781211-A1 (EP)
Inventor: SJÖÖ MALIN
IPC: C09K23/00
Filed: 2019-04-16
Abstract: The present invention relates to a powder composition for cosmetic and health use comprising a dehydrated oil-in-water emulsion comprising at least one oil phase, natural starch particles, optionally fused starch particles, and optionally additionally additives, wherein the powder composition comprises at least 55% by weight of said at least one oil phase, optionally including at least one additive, in the form of starch covered oil spheres and wherein said dehydrated oil-in-water emulsion is formed from a Pickering oil-in-water emulsion.
Patent EP-3784885-A1 (EP)
Title: Method and contol system for control of dosage of a reducing agent
Inventor: LUNDBERG CHRISTER
IPC: F01N3/20
Filed: 2019-04-18
Abstract: A method, a system, a computer program and a computer-readable medium for control of dosage of a reducing agent into an exhaust stream from an engine are disclosed. The method method includes: - determining at least one sensor signal S NOx  from at least one nitrogen oxides N0 x  sensor arranged downstream of at least one of the one or more reduction catalysts as at least one sensor correction value S NOx corr , respectively, if: - the engine revolves without fuel supply; - an exhaust mass flow M exh  is greater than an exhaust mass flow threshold M exh 
 th ; M exh >M exh th ; and - the at least one sensor signal S NOx  has had a value smaller than a sensor signal threshold S NOx th ; S NOx <S NOx th ; during at least a predetermined time period T con ; - determining at least one adjusted sensor signal S NOx adj  based on the at least one sensor signal S NOx  and the at least one sensor correction value S NOx corr , respectively; and - controlling the dosage of the reducing agent based on the at least one adjusted sensor signal S NOx adj  .
Patent EP-3863560-A1 (EP)
Inventor: WANG TIANYI
IPC: A61C17/02
Filed: 2019-10-10
Abstract: A nozzle member (14) of a personal care device (10) comprising: a nozzle head (16) positioned at an end of the nozzle member; and an orifice (40) formed in a surface (30) of the nozzle head, wherein the orifice comprises at least one liquid jet orifice (42) configured to allow the liquid and/or air to exit the nozzle head in the form of a jet, and at least one liquid sheet orifice (40a-d) configured to allow the liquid and/or air to exit the nozzle head in the form of a sheet.
Patent EP-3870063-A1 (EP)
Inventor: CHAO PEI-YIN
IPC: A61B8/00
Filed: 2019-10-24
Abstract: Disclosed is an intraluminal ultrasound imaging system, comprising a processor circuit in communication with an intraluminal ultrasound imaging catheter, and configured to receive an intraluminal ultrasound image from the imaging catheter within a body lumen of a patient, the body lumen comprising a plurality of segments. The processor is configured to identify a segment of the plurality of segments where the imaging catheter was located when the image was obtained, and output to a display a stylized figure of the body lumen including the plurality of segments, and an indicator identifying the segment in the stylized figure where the imaging catheter was located when the image was obtained.
Patent EP-3870916-A1 (EP)
Title: Verfahren zur gewinnung eines oder mehrerer luftprodukte und luftzerlegungsanlage
Inventor: GOLUBEV DIMITRI
IPC: F25J3/04
Filed: 2019-10-09
Abstract: Die Erfindung schlägt ein Verfahren zur Gewinnung eines oder mehrerer Luftprodukte unter Verwendung einer Luftzerlegungsanlage (100) mit einem ersten Booster (1), einem zweiten Booster (2), einer ersten Entspannungsmaschine (1a) und einem Rektifikationssäulensystem (10), das eine Hochdrucksäule (11), die auf einem ersten Druckniveau betrieben wird, und eine Niederdrucksäule (12), die auf einem zweiten Druckniveau unterhalb des ersten Druckniveaus betrieben wird, aufweist, vor. Dabei wird die gesamte, dem Rektifikationssäulensystem (10) zugeführte Luft zunächst als Einsatzluftmenge auf ein drittes Druckniveau verdichtet, das mindestens 3 bar oberhalb des ersten Druckniveaus liegt. Es ist vorgesehen, dass ein erster Anteil der Einsatzluftmenge auf dem dritten Druckniveau und einem Temperaturniveau von -140 bis -70 °C einem ersten Booster (1) zu geführt und unter Verwendung des ersten Boosters (1) auf ein viertes Druckniveau verdichtet wird, dass ein zweiter Anteil der Einsatzluftmenge oder eine Teilmenge der ersten Einsatzluftmenge, die unter Verwendung des ersten Boosters (1) auf das vierte Druckniveau verdichtet wurde, einer ersten Entspannungsturbine (1a), unter Verwendung derer der erste Booster (1) angetrieben wird, zugeführt und unter Verwendung der ersten Entspannungsmaschine (1a) auf das erste Druckniveau entspannt wird, und dass eine Teilmenge der ersten Einsatzluftmenge, die unter Verwendung des ersten Boosters (1 ) auf das vierte Druckniveau verdichtet wurde, einem zweiten Booster (2) zu geführt und unter Verwendung des zweiten Boosters (2) auf ein fünftes Druckniveau verdichtet wird. Der erste Anteil der Einsatzluftmenge liegt am Austritt des ersten Boosters (1) auf einem Temperaturniveau von -100 bis -60 °C vor und die Teilmenge der ersten Einsatzluftmenge, die unter Verwendung des zweiten Boosters (2) auf das fünfte Druckniveau verdichtet wird, wird vor ihrer Verdichtung in dem zweiten Booster (2) auf ein Temperaturniveau von -20 bis 40 °C erwärmt. Eine entsprechende Luftzerlegungsanlage ist ebenfalls Gegenstand der Erfindung.
Patent EP-3870127-A1 (EP)
Inventor: JACKSON DAMIAN
IPC: B60P3/079
Filed: 2019-10-24
Abstract: An occupancy sensor is provided for detecting the occupancy status of a wheeled mobility device securement system. The occupancy sensor may additionally confirm adequate "tightness" of the wheeled mobility device securement system and/or provide an indication of the magnitude of "tightness." In one embodiment, the occupancy sensor comprises a spring-loaded follower that breaks the straight-line path of a wheeled mobility device tie down as it travels between two touch points. The follower is displaceable from an extended position to a compressed position in response to the magnitude of tension applied to the tie down. Proximity sensors are used to detect the displacement distance of the follower, thereby providing an indication of occupancy, adequate securement, and/or the magnitude of tension.
Patent EP-3801489-A1 (EP)
Inventor: TAYLOR STEVEN JOHN
IPC: C07D311/04
Filed: 2019-06-05
Abstract: Disclosed herein are acylated active agents (e.g., acylated catechin polyphenols, acylated carotenoids, acylated mesalamines, acylated sugars, acylated shikimic acids, acylated ellagic acid, acylated ellagic acid analogue, and acylated hydroxybenzoic acids), active agent combinations (e.g., with a second agent that is a fatty acid) and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.
Patent EP-3898946-A1 (EP)
Title: Mucosal-associated invariant t (mait) cells expressing chimeric antigen receptors
Inventor: LANTZ OLIVIER
IPC: A61P37/00
Filed: 2019-12-18
Abstract: The present invention relates generally to immunotherapy, in particular immunotherapy for treating cancer, infectious diseases or autoimmune diseases. More specifically, the invention relates to Mucosal-Associated Invariant T (MAIT) cells expressing Chimeric Antigen Receptors (CARs), wherein the MAIT cell is allogenic with respect to the subject to be treated.
Patent EP-3816221-A1 (EP)
Inventor: FUKUMINE YOSHIO
IPC: C08K3/36
Filed: 2019-06-21
Abstract: The present invention provides a cross-linkable nitrile rubber composition comprising: nitrile group-containing copolymer rubber (A) containing an α,β-ethylenically unsaturated nitrile monomer unit, a conjugated diene monomer unit, an α,β-ethylenically unsaturated monocarboxylic acid ester monomer unit, and carboxyl group-containing monomer unit, a content ratio of the α,β-ethylenically unsaturated nitrile monomer unit being 8 to 18 wt%, and having an iodine value of 120 or less; silica (B1); clay (B2); calcium carbonate (B3); and a polyamine-based cross-linking agent (C), wherein a total amount of the silica (B1), the clay (B2), and the calcium carbonate (B3) is 150 to 200 parts by weight with respect to 100 parts by weight of the nitrile group-containing copolymer rubber (A), a content ratio of the silica (B1) is greater than 0 wt% and 50 wt% or less with respect to the total amount of the silica (B1), the clay (B2), and the calcium carbonate (B3), and a content ratio of the clay (B2) and the calcium carbonate (B3) is 30:70 to 90:10 in a weight ratio of "clay (B2):calcium carbonate (B3)".
Patent EP-3884387-A1 (EP)
Inventor: CALDWELL ANDREW EDWARD
IPC: G06F9/50
Filed: 2019-12-02
Abstract: Techniques for multi-tenant storage for analytics with push down filtering are described. A multi-tenant storage service can include resources can be grouped into racks, with each rack providing a distinct endpoint to which client services may submit queries. Each rack may include interface nodes and storage nodes. The interface nodes can preprocess queries that are received by splitting them into chunks to be executed by the storage nodes. Each storage node includes a field programmable gate array (FPGA) and a CPU. The CPU can receive the operations and convert the operations into instructions that can be executed by the FPGA. The instructions may include pointers to data and operations for the FPGA to perform on the data. The FPGA can process the data stream and return the results of the processing which are returned via the interface node.
Patent EP-3906472-A1 (EP)
Inventor: ARORA AMIT
IPC: G06F9/50
Filed: 2019-12-17
Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for determining availability of network service. In some implementations, a request indicating a location and a communication service level is received. A first subset of service providers or communication technologies is determined based on outputs generated by multiple first machine learning models each trained to predict service availability for different service providers or communication technologies. A second subset is selected from the first subset based on outputs generated by multiple second machine learning models trained to predict availability of different communication service levels for different service providers or communication technologies. At least one service provider or communication technology is selected from the second subset based on output generated by a third machine learning model. A response to the request indicating the selected service provider or communication technology is provided.
Patent EP-3834193-A1 (EP)
Inventor: DONG TIAN
IPC: G09G3/3266
Filed: 2019-06-28
Abstract: A display panel, which may include a pixel unit group and a scanning circuit (130). The pixel unit group may include a first pixel unit (P1) and a second pixel unit (P2). The scanning circuit (130) may include a first scan signal terminal (OUT1) and a second scan signal terminal (OUT2). The first scan signal terminal (OUT1) may be configured to simultaneously provide a same gate signal to the first pixel unit (P1) and the second pixel unit (P2), and/or the second scan signal terminal (OUT2) may be configured to simultaneously provide a same light emitting control signal to the first pixel unit (P1) and the second pixel unit (P2).
Patent EP-3834286-A1 (EP)
Title: Channel switchover power multiplexer circuits, and methods of operating the same
Inventor: CHOI JAE WON
IPC: H03K17/00
Filed: 2019-08-09
Abstract: An example power multiplexer (100) includes: a first transistor (105) coupled to a first input (102); a second transistor (106) coupled to the first transistor (105) to couple a first voltage at the first input (102) to an output (101); a third transistor coupled to a second input; a fourth transistor coupled to the third transistor to couple a second voltage at the second input to the output (101); a diode amplifier (142) to provide a third voltage to a gate (105C) of the first transistor (105) to block a reverse current; and a soft-start amplifier to provide a fourth voltage to a gate of the fourth transistor to turn on the fourth transistor with a constant ramp rate.
Patent EP-3842441-A1 (EP)
Inventor: WHANG SU-KYEONG
IPC: C07F3/02
Filed: 2019-02-12
Abstract: The present invention relates to a novel magnesium-serinate compound and the use thereof, and more particularly, to a novel magnesium-serinate compound in which a magnesium atom is chelated to L-serine, and the pharmaceutical use thereof against central nervous system diseases or the like. It was confirmed that the novel magnesium-serinate composition obtained by the production method of the present invention consisted of about 10% magnesium and about 90% serine, as determined by instrumental analysis, was solubilized at a concentration of about 500 mg/ml in water at room temperature at a pH of 6.0 to 10.0, was maintained in an aqueous solution state without forming a precipitate, and was also solubilized at a concentration of about 500 mg/ml in phosphate-buffered saline (PBS) solution at room temperature without forming a precipitate. Thus, the novel magnesium-serinate composition has properties suitable for administration orally or by injection to the human body. In addition, the compound activates mitochondrial function and neuronal cell proliferation by increasing the oxygen consumption rate of mitochondria, and exhibits a neuronal protective effect of inhibiting neuronal cell death resulting from mitochondrial membrane potential damage and/or endoplasmic reticulum stress caused by oxidative stress, and exhibits improved blood-brain barrier permeability. Therefore, the compound has an excellent effect on the prevention, treatment and alleviation of central nervous system diseases such as cognitive disorder, intellectual disability, microcephaly, epilepsy, neurodevelopmental disorder, dementia, autism spectrum disorder, Down's syndrome, Rett's syndrome, fragile X syndrome, Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, and thus is a highly useful invention in the pharmaceutical industry, etc.
Patent EP-3813142-A1 (EP)
Inventor: BAE KWAN HONG
IPC: B23K101/36
Filed: 2019-08-19
Abstract: The present invention relates to a cylindrical battery in which an electrode assembly is housed in a cylindrical can, including: a cap assembly covering an upper opening of the cylindrical can; and a gasket disposed in a space between the cylindrical can and the cap assembly, wherein the gasket is disposed on a crimping part formed by processing an end part of the cylindrical can to be bent, and an exposed part of the gasket protruded outside from a space between the cylindrical can and the cap assembly covers a trimming part of the cylindrical can.
Patent EP-3858767-A1 (EP)
Inventor: GUENER TILL
IPC: B65G47/88
Filed: 2019-08-29
Abstract: A stopper (4) for a transmission system (10) and the transmission system (10). The stopper (4) comprises a base (40) and a first piston assembly (41) disposed inside of the base (40); the first piston assembly (41) comprises a tubular part (411) and a first core part (412); the tubular part (411) comprises a damping cavity (411A), and the damping cavity (411A) has a pressure medium inside; the first core part (412) has a first movement direction relative to the base (40), and the first core part (412) comprises a rod part (4120) and a stopping part (4121) at a free end of the rod part (4120); the first piston assembly (41) has a second movement direction relative to the base (40), said second movement direction being perpendicular to the first movement direction. The stopper can stop trays by means of damping.
Patent EP-3849425-A1 (EP)
Inventor: BANJANIN ZORAN
IPC: A61B8/08
Filed: 2019-09-11
Abstract: An ultrasound imaging system performs spectral Doppler processing in a manner that considers a physiological cycle of a subject. In one embodiments, gaps in a spectral Doppler signal are filled taking by a processor that analyzes changes in the spectral Doppler signal caused by a physiological cycle. Spectral Doppler data are scaled to fit with the data occuring before and after a gap. The firing order of an interleaved imaging mode can also be adjusted so that spectral Doppler imaging is not interrupted during pre-defined or user defined portions of a physiological cycle.
Patent EP-3865570-A1 (EP)
Inventor: TSUJI TAKASHI
IPC: A61L27/38
Filed: 2019-09-19
Abstract: [PROBLEM] To provide means for efficient growth of epithelial cells capable of being used to manufacture regenerated hair follicle germs. 
     [SOLUTION MEANS] Provided are a culture medium for growth of epithelial cells capable of being used to manufacture regenerated hair follicle germs, the culture medium comprising basal medium and at least (1) through (3) below; and a method for growing the epithelial cells using the culture medium: (1) at least one species of BMP inhibitor; (2) at least one species of fibroblast growth factor; and (3) at least one species of sonic hedgehog (SHH) and/or SHH agonist.
Patent EP-3860360-A1 (EP)
Inventor: SHULMAN TAYLOR
IPC: C12G3/04
Filed: 2019-10-01
Abstract: L'invention concerne des substances et des procédés de production de boissons alcoolisées de type Scotch à partir de composants individuels.
Patent EP-3863812-A1 (EP)
Inventor: KNUEPFEL MICHAEL HAZEN
IPC: B25J5/04
Filed: 2019-10-12
Abstract: Provided is a process, including: engaging, with a first subset of end effectors of a robot, a first open-top vessel; engaging, while the first subset of end effectors are engaged with the first open-top vessel, with a second subset of end effectors of the robot, a second open-top vessel; concurrently transporting the first open-top vessel and the second open-top vessel with two or more actuators; disengaging the first open-top vessel at a first workstation of the robot, the first workstation being configured to dispense a first alimentary product into the first open- top vessel; and disengaging the second open-top vessel at a second workstation of the robot, the second workstation being configured to dispense a second alimentary product into the second open-top vessel.
Patent EP-3883552-A1 (EP)
Inventor: KINCAID JOHN
IPC: A61K31/136
Filed: 2019-11-20
Abstract: Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating diseases or disorders in a subject where the subject is in need of an inhibitor of MEK where the compound is according to formula where R 1 , R 2 , R 2a , R 3 , R 3a , and X are as described herein.